09/06/2024
3:22 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2024
3:34 PM | Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024
4:42 PM | Cox John (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
5:14 PM | Dyne Therapeutics (Issuer)
Kerr Douglas (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/03/2024
5:16 PM | Dyne Therapeutics (Issuer)
Friedl-Naderer Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
5:20 PM | Dyne Therapeutics (Issuer)
Friedl-Naderer Johanna (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/03/2024
5:22 PM | Dyne Therapeutics (Issuer)
Kerr Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
09/03/2024
6:16 AM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2024
3:05 PM | Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2024
3:05 PM | Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:05 PM | Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:26 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:26 PM | Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:27 PM | Dyne Therapeutics (Issuer)
Farwell Wildon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:27 PM | Dyne Therapeutics (Issuer)
McNeill Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:28 PM | Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
3:13 PM | Dyne Therapeutics (Subject)
Farwell Wildon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
3:08 PM | Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
3:10 PM | Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
3:11 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
3:12 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
4:15 PM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
4:05 PM | Dyne Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
3:37 PM | Dyne Therapeutics (Subject)
Forbion Capital Fund IV Cooperatief U.A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2024
8:00 PM | Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
| Form 4/A | |
06/24/2024
7:41 PM | Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
8:45 PM | Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:41 PM | Dyne Therapeutics (Issuer)
Farwell Wildon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:42 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:28 PM | Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:34 PM | Dyne Therapeutics (Issuer)
McNeill Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:34 PM | Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
3:32 PM | Dyne Therapeutics (Subject)
Farwell Wildon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
3:33 PM | Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
3:36 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2024
4:10 PM | Dyne Therapeutics (Issuer)
Lubner David Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
4:10 PM | Dyne Therapeutics (Issuer)
Rhodes Jason P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
4:10 PM | Dyne Therapeutics (Issuer)
HURWITZ EDWARD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
4:10 PM | Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
4:10 PM | Dyne Therapeutics (Issuer)
Incerti Carlo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
4:10 PM | Dyne Therapeutics (Issuer)
Stehman-Breen Catherine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Pre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳 (Ad) 45M Users | 32,481% Growth Rate
Get in on the biggest disruption to smartphones in over a decade. Reg A investment now open. Claim Exclusive 100% Bonus: $0.25/Share |
05/22/2024
8:01 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:30 PM | Dyne Therapeutics (Filer)
| Form 424B5 | |
05/22/2024
6:59 AM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
5:00 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024
3:24 PM | Dyne Therapeutics (Filer)
| Form 424B5 | |
05/20/2024
6:37 AM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2024
8:03 PM | Dyne Therapeutics (Issuer)
McNeill Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
8:04 PM | Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
8:05 PM | Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
8:06 PM | Dyne Therapeutics (Issuer)
Farwell Wildon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
8:07 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
3:28 PM | Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024
3:15 PM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
3:25 PM | Dyne Therapeutics (Filer)
| Form ARS | |
04/05/2024
3:15 PM | Dyne Therapeutics (Filer)
| Form DEF 14A | |
04/05/2024
3:20 PM | Dyne Therapeutics (Filer)
| Form DEFA14A | |
04/04/2024
8:06 PM | Dyne Therapeutics (Issuer)
McNeill Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
8:07 PM | Cox John (Reporting)
Dyne Therapeutics (Issuer)
| Form 3/A | |
04/04/2024
6:04 PM | Dyne Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
04/04/2024
3:22 PM | Brumm Joshua T (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/27/2024
3:24 PM | Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
3:24 PM | Cox John (Reporting)
Cox John (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
6:39 AM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
5:04 AM | Dyne Therapeutics (Issuer)
McNeill Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
5:04 AM | Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
8:56 PM | Brumm Joshua T (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
8:57 PM | Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
8:58 PM | Dyne Therapeutics (Issuer)
Farwell Wildon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
8:42 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:56 PM | Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:56 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:57 PM | Brumm Joshua T (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:45 PM | Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:50 PM | Dyne Therapeutics (Issuer)
McNeill Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:52 PM | Dyne Therapeutics (Issuer)
Farwell Wildon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:35 PM | Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
4:35 PM | Dyne Therapeutics (Subject)
Farwell Wildon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
4:36 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
4:32 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
4:33 PM | Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
4:34 PM | Brumm Joshua T (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
3:51 PM | Brumm Joshua T (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
3:53 PM | Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
3:53 PM | Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
3:54 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
7:17 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
7:17 PM | Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
7:18 PM | Brumm Joshua T (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
7:18 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
7:19 PM | Dyne Therapeutics (Subject)
Farwell Wildon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Biden's Successor: The Radical Threat to YOUR Savings! (Ad) Kamala Harris isn't just playing politics; she's a serious threat to your financial security.
Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL. >> Get Your FREE Wealth Protection Guide << |
03/07/2024
7:16 PM | Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
4:07 PM | Atlas Venture Associates Opportunity I, L.P. (Reporting)
Atlas Venture Associates Opportunity I, LLC (Reporting)
Atlas Venture Associates Opportunity II, LLC (Reporting)
Atlas Venture Associates Opportunity II, LP (Reporting)
Atlas Venture Opportunity Fund I, L.P. (Reporting)
Atlas Venture Opportunity Fund II, L.P. (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:08 PM | Dyne Therapeutics (Issuer)
Rhodes Jason P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:22 AM | Dyne Therapeutics (Filer)
| Form S-3ASR | |
03/05/2024
6:35 AM | Dyne Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/05/2024
6:40 AM | Dyne Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/05/2024
6:41 AM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
8:33 PM | Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
8:33 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
